Maternal mean arterial pressure and serum inhibin A as early predictors of hypertensive disorders in low‐risk pregnant women attending a University Teaching Hospital in Lagos, Nigeria: A prospective cohort study
OBJECTIVE: This study evaluates the role of maternal mean arterial pressure (MAP) and serum inhibin-A level as early predictors of hypertensive disorders of pregnancy (HDP) among low-risk pregnant women attending a University Teaching Hospital in Lagos, Nigeria. METHODS: This was a prospective cohort study of 254 consecutively consenting, low-risk, normotensive, and non-proteinuric pregnant women at 13-19 weeks of gestation. Receiver operating characteristics (ROC) curves and validity tests were used to determine the performance of serum levels of inhibin A, MAP, and a combination of both in predicting HDP (gestational hypertension and preeclampsia). RESULTS: The mean age and parity of the participants was 30.3 ± 4.9 years and 1 (0-2), respectively. The area under the ROC curves of serum inhibin A (0.9981, 95% confidence interval [CI]: 0.9946-1.000) was higher than for MAP (0.7531, 95% CI 0.6641-0.8421), in predicting the composite endpoint of HDP. The optimum cut-offs for predicting HDP as calculated from Youden's index were 476.8 pg/mL (sensitivity = 100% and specificity = 98.7%) for serum inhibin A and 81.3 mm Hg (sensitivity = 100% and specificity = 50.1%) for MAP. There was no statistically significant difference between the combined predictive ability of inhibin A and MAP compared to that of serum inhibin A alone for predicting HDP (AUC of 0.9984 vs. 09981, P-value = 0.7259. CONCLUSION: This study demonstrated that serum inhibin A alone and MAP have good and moderate performance, respectively, in predicting HDP in the low-risk cohort of Nigerian pregnant women. The combination of serum inhibin A and MAP has a similar predictive performance as serum inhibin A alone.
Authors
- Ayodeji Ayotunde Oluwole (ORCID: https://orcid.org/0000-0001-7719-0015)
- Kehinde S. Okunade (ORCID: https://orcid.org/0000-0002-0957-7389)
- Gbenga Olorunfemi (ORCID: https://orcid.org/0000-0001-6634-8550)
- Nnabuike Chibuoke Ngene (ORCID: https://orcid.org/0000-0002-2278-5836)
- Oladayo J. Kuku (ORCID: https://orcid.org/0000-0001-8951-7716)
Institutions
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of the Witwatersrand (ZA)
- University of Lagos (NG)
- Johannesburg Hospital (ZA)
- Lagos University Teaching Hospital (NG)
- Mother Hospital (IN)
Publication Details
- Journal
- International Journal of Gynecology & Obstetrics
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1002/ijgo.71418
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- GlaxoSmithKline
- GlaxoSmithKline foundation